Show
Sort by
-
Baseline-Charakteristika von Patienten mit chronischer Rhinosinusitis mit nasalen Polypen (mit und ohne Asthma) in SINUS-52 : einer randomisierten, doppel-blinden, Phase-3-Studie von Dupilumab
-
Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps (with and without asthma) enrolled in SINUS-52 : a randomized, double-blind, phase 3 study of dupilumab
-
Baseline characteristics of phase 3 randomized controlled trials of omalizumab in chronic rhinosinusitis with nasal polyps
-
Patient advisory board for chronic rhinosinusitis : a EUFOREA initiative
-
Real-life assessment of chronic rhinosinusitis patients using mobile technology
-
ARIA-Versorgungspfade für die Allergenimmuntherapie 2019 = 2019 ARIA Care pathways for allergen immunotherapy
-
- Journal Article
- A1
- open access
Guidance to 2018 good practice : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
-
Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and NSAID-ERD
-
Dupilumab improves ACQ-5 items in CRSwNP patients with comorbid asthma
-
Impact of chronic rhinosinusitis with nasal polyposis on quality of life by sino-nasal surgery history